Autopsy report · NCT00863057

Combination Pain Therapy in HIV Neuropathy

“Due to slow rate of enrollment, which compromised the ability to meet study objectives in a timely manner.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 1 year 7 months before it stopped.
• 15 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Sponsor type

US National Institutes of Health

Conditions

HIV Infections; Peripheral Neuropathy

Interventions

Duloxetine; Duloxetine placebo; Methadone; Methadone placebo

Participants

15

Sites

8

Countries

United States

Trials that died the same way

• Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Implant vs. a Bioabsorbable Nasal Dressing
  “Study enrollment was too slow to complete the study in a reasonable time” (79% match in meaning)
• The Impact of Nebivolol Versus Metoprolol on Quality of Life
  “due to slow enrollment” (76% match in meaning)
• Study in Adult Subjects Undergoing Posterolateral Thoracotomy
  “Slow study enrollment” (74% match in meaning)
• T2 FSL2 Weight Loss
  “Slow enrollment and Study no longer required” (73% match in meaning)
• Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC
  “Due to the enrollment was slow and exceeded the expected enrollment time” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.